Bafazol IC 10mg 40 tablets — Made in Ukraine — Free Delivery

Product description

Bafazol IC is a preparation that affects the nervous system. Psycholeptic preparations.

The preparation is indicated for use in adults for the treatment of anxiety states: generalized anxiety disorders, neurasthenia, adaptation disorders, patients with various somatic diseases (bronchial asthma, irritable bowel syndrome, systemic lupus erythematosus, coronary heart disease, arterial hypertension, arrhythmias), dermatological, oncological and other diseases.

The preparation is used to treat sleep disorders associated with anxiety; neurocirculatory dystonia, premenstrual syndrome, alcohol withdrawal syndrome, to relieve the withdrawal syndrome when quitting smoking.

Storage

active ingredient: fabomotizole;

1 tablet contains fabomotizole dihydrochloride 10 mg;

excipients: potato starch, microcrystalline cellulose, StarLac® (lactose monohydrate, corn starch), talc, colloidal anhydrous silicon dioxide, magnesium stearate.

Contraindication

Individual intolerance to any components of the medicinal product. Galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome. The period of pregnancy and breastfeeding. Children's age up to 18 years.

Adverse reactions

Allergic reactions are possible.

Rarely – a headache that usually goes away on its own and does not require discontinuation of the preparation.

Application method

Apply internally after meals.

The optimal single dose is 10 mg, the daily dose is 30 mg, which should be divided into 3 doses during the day. The duration of the treatment course is 2–4 weeks.

If necessary, according to the doctor's recommendation, the daily dose of the preparation can be increased to 60 mg, and the duration of treatment - up to 3 months.

Features of application

Patients with established intolerance to some sugars should consult a doctor before using the medicine.

Due to the lactose content, the preparation should not be taken by patients with rare hereditary galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome.

Use during pregnancy or breastfeeding

Use of the preparation during pregnancy is contraindicated.

During the period of use of the medicinal product, breastfeeding should be stopped.

Children

The use of the medicinal product by children under the age of 18 is contraindicated.

The ability to influence the speed of reaction when driving vehicles or other mechanisms

The preparation does not have a negative effect on the ability to drive vehicles and the ability to perform potentially dangerous activities that require increased concentration of attention and speed of psychomotor reactions.

Overdose

With a significant overdose and intoxication, the development of a sedative effect and increased drowsiness without manifestations of muscle relaxation is possible.

Treatment. Caffeine, a 20% solution for injections of 1 ml 2-3 times a day subcutaneously should be used as measures of emergency therapy.

Interaction with other medicinal products and other types of interactions

Fabomotizole does not interact with ethanol, does not affect the hypnotic effect of thiopental. Enhances the anticonvulsant effect of carbamazepine. Causes an increase in the anxiolytic effect of diazepam.

Storage conditions

Store in the original packaging at a temperature not higher than 25 ºС.

Keep out of the reach of children.